DPYD and colorectal carcinoma: Moreover, Kristensen et al. also revealed that sequence variations in the DPYD gene may influence the breakdown of the common anticancer drug 5-FU and provoke severe drug adverse effects in CRC patients receiving 5-FU therapy [9].